Salbutamol Completed Phase N/A Trials for Chronic Obstructive Pulmonary Disease (COPD)

CompletedNot AvailableNot Available IdentifierTitleDrugs
NCT01395875Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment
NCT01332461Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies
NCT01331694Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)